Differences in asthma study models and the effectiveness of β(2)‐adrenoceptor ligands: response to Lipworth et al.

Documenti analoghi

• Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
  di: Moran, Angela M., et al.
  Pubblicazione: (2020)
• New perspectives regarding β(2)-adrenoceptor ligands in the treatment of asthma
  di: Walker, JKL, et al.
  Pubblicazione: (2011)
• β-Adrenoceptor Inverse Agonists in Asthma
  di: Dickey, Burton F., et al.
  Pubblicazione: (2010)
• Ligand bias prevents class equality among beta-blockers
  di: Thanawala, Vaidehi J, et al.
  Pubblicazione: (2014)
• Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β(2)-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase–Knockout Mice
  di: Forkuo, Gloria S., et al.
  Pubblicazione: (2016)